al. (2013) and Kwan et. al. (2013) reported that activation of AMP-activated protein kinase (AMPK), a metabolic sensor, hinders cervical cancer cell growth through reducing the expression of FOXM1 and blocking the DVL3 mediated Wnt/β-catenin signaling pathway45,46. This evidence concerns the gene FOXM1 and cervical carcinoma.